연구동향 분석

Is High-Dose Leuprorelin Acetate Effective and Safe in Asian Men with Prostate Cancer? An Open-Label, Non-Comparative, Multi-Center Clinical Trial

이승환 정병하 이현무 김세웅 이은식 홍성준 김청수 강택원 2014년

논문상세정보
인용/피인용
' Is High-Dose Leuprorelin Acetate Effective and Safe in Asian Men with Prostate Cancer? An Open-Label, Non-Comparative, Multi-Center Clinical Trial' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • adverse events
  • luteinizinghormonereleasinghormoneagonist
  • prostate cancer
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,703 0

0.0%

' Is High-Dose Leuprorelin Acetate Effective and Safe in Asian Men with Prostate Cancer? An Open-Label, Non-Comparative, Multi-Center Clinical Trial' 의 참고문헌

  • Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists
    Tolis G Proc Natl Acad Sci U S A 79 1658-1662 [1982]
  • Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes
    Agarwal PK Cancer 112 307-314 [2008]
  • The effect of baseline testosterone on the efficacy of degarelix and leuprolide: further insights from a 12-month, comparative, phase III study in prostate cancer patients
    Damber JE Urology 80 174-180 [2012]
  • The Change of Prostate Cancer Treatment in Korea: 5 Year Analysis of a Single Institution
    이동훈 Yonsei Medical Journal 54 1 87-91 [2013]
  • Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941
    Huggins C J Urol 168 9-12 [2002]
  • Serum testosterone--a significant determinant of metastatic relapse for irradiated localized prostate cancer
    Zagars GK Urology 49 327-334 [1997]
  • Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada
    Wu AH Cancer Epidemiol Biomarkers Prev 4 735-741 [1995]
  • Racial differences in the androgen/androgen receptor pathway in prostate cancer
    Pettaway CA J Natl Med Assoc 91 653-660 [1999]
  • Prostate cancer: screening and early detection
    Cookson MM Cancer Control 8 133-140 [2001]
  • Predicting penile size during erection
    Chen J Int J Impot Res 12 328-333 [2000]
  • Obesity and sex steroids during gonadotropin-releasing hormone agonist treatment for prostate cancer
    Smith MR Clin Cancer Res 13 241-245 [2007]
  • Impacts of leuprolide acetate on quality of life in patients with prostate cancer: A prospective multicenter study
    You D SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY 44 399-405 [2010]
  • Failure to maintain a suppressed level of serum testosterone during long-acting depot luteinizing hormone-releasing hormone agonist therapy in patients with advanced prostate cancer
    Morote J Urol Int 77 135-138 [2006]
  • Failure to achieve castrate levels of testosterone during luteinizing hormone releasing hormone agonist therapy: the case for monitoring serum testosterone and a treatment decision algorithm
    Oefelein MG J Urol 164 3 Pt 1 726-729 [2000]
  • Effect of a new leuprorelin formulation on testosterone levels in patients with advanced prostate cancer
    Berges R Curr Med Res Opin 22 649-655 [2006]
  • Development and Validation of the Korean Version of Expanded Prostate Cancer Index Composite: Questionnaire Assessing Health-Related Quality of Life after Prostate Cancer Treatment
    정경진 Korean Journal of Urology 51 9 601-612 [2010]
  • Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer
    Heyns CF BJU Int 92 226-231 [2003]
  • Clinical measurement of testicular volume in adolescents: comparison of the reliability of 5 methods
    Chipkevitch E J Urol 156 2050-2053 [1996]
  • A clinical study of 22.5 mg. La-2550: a new subcutaneous depot delivery system for leuprolide acetate for the treatment of prostate cancer
    Chu FM J Urol 168 1199-1203 [2002]